Today's Daily Dose brings you news about Alnylam Pharma's regulatory catalyst in December; argenx' generalized myasthenia gravis trial data; Atara's multiple sclerosis trial data and stock offering; Merck's deals and collaboration to develop an effective response to the COVID-19 pandemic; Novavax' progress in a COVID-19 vaccine trial and Osmotica Pharma's near-term catalysts.
from RTT - Biotech https://ift.tt/2ZAEloC
via IFTTT
No comments:
Post a Comment